Cargando…
An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
Anecdotal and scientific evidence suggests that Cannabis use may be beneficial in inflammatory bowel disease (IBD) patients. Here, we have investigated the effect of a standardized Cannabis sativa extract with high content of cannabidiol (CBD), here named CBD BDS for “CBD botanical drug substance,”...
Autores principales: | Pagano, Ester, Capasso, Raffaele, Piscitelli, Fabiana, Romano, Barbara, Parisi, Olga A., Finizio, Stefania, Lauritano, Anna, Marzo, Vincenzo Di, Izzo, Angelo A., Borrelli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047908/ https://www.ncbi.nlm.nih.gov/pubmed/27757083 http://dx.doi.org/10.3389/fphar.2016.00341 |
Ejemplares similares
-
Fish Oil, Cannabidiol and the Gut Microbiota: An Investigation in a Murine Model of Colitis
por: Silvestri, Cristoforo, et al.
Publicado: (2020) -
Dysfunctional endocannabinoid CB1 receptor expression and signaling contribute to skeletal muscle cell toxicity induced by simvastatin
por: Kalkan, Hilal, et al.
Publicado: (2023) -
Palmitoylethanolamide Reduces Colon Cancer Cell Proliferation and Migration, Influences Tumor Cell Cycle and Exerts In Vivo Chemopreventive Effects
por: Pagano, Ester, et al.
Publicado: (2021) -
Increased endocannabinoid levels reduce the development of precancerous lesions in the mouse colon
por: Izzo, Angelo A., et al.
Publicado: (2007) -
N‐Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth
por: Romano, Barbara, et al.
Publicado: (2021)